
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Gesamtverbindlichkeiten 2011-2026 | VIVO
Gesamtverbindlichkeiten Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 135 M | 76 M | 80.2 M | 85.4 M | 17.4 M | 15.9 M | 21.7 M | 18.6 M | 17 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 135 M | 15.9 M | 51.8 M |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
2.66 B | $ 13.28 | -1.96 % | $ 3.77 B | ||
|
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | ||
|
Biodesix
BDSX
|
76.4 M | $ 14.59 | -0.07 % | $ 1.89 B | ||
|
Agilent Technologies
A
|
5.32 B | $ 110.88 | -2.29 % | $ 33.7 B | ||
|
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
29.2 M | $ 1.15 | - | $ 6.26 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.57 | -10.43 % | $ 178 M | ||
|
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
3.59 B | $ 62.48 | -5.47 % | $ 24.4 B | ||
|
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
9.31 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
90.8 M | $ 15.62 | -4.64 % | $ 472 M | ||
|
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
2.11 B | $ 85.04 | -3.47 % | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
75.4 M | $ 24.15 | -2.23 % | $ 671 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
3.92 B | $ 158.32 | -4.12 % | $ 7.85 B | ||
|
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 196.15 | -1.01 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
4.16 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
2.48 M | - | -16.95 % | $ 1.54 M | ||
|
ICON Public Limited Company
ICLR
|
7.35 B | $ 101.83 | -1.21 % | $ 8.4 B | ||
|
DarioHealth Corp.
DRIO
|
7.26 M | $ 8.45 | - | $ 33.7 M | ||
|
Illumina
ILMN
|
2.7 B | $ 117.51 | -5.54 % | $ 18.7 B | ||
|
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
4.92 B | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
17 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
23.3 B | $ 164.58 | -2.85 % | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
1.37 B | $ 8.84 | -3.39 % | $ 1.92 B | ||
|
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
67.3 M | $ 6.4 | -12.64 % | $ 379 M | ||
|
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 266.29 | -0.78 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
65.2 M | $ 6.54 | -0.3 % | $ 273 M | ||
|
Psychemedics Corporation
PMD
|
5.65 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
3.67 M | $ 26.03 | -1.92 % | $ 33.8 M | ||
|
CareDx, Inc
CDNA
|
110 M | $ 16.83 | -3.66 % | $ 897 M | ||
|
Quotient Limited
QTNT
|
255 M | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
4.82 B | - | - | $ 4.46 B |